David Horrobin Bibliography
1997
722
Bordoni, A.; Lorenzini, A.; Horrobin, D.F.; Biagi, P.L.; Hrelia, S.
Manipulation of lipid composition of rat heart myocytes aged in culture and its effect on alpha1-adrenoceptor stimulation
Biochim Biophys Acta 1997; 1348(3): 339-45.
(Abstract)


723
Burke, M.; Redden, P.R.; Douglas, J.-A.; Dick, A.; Horrobin, D.F.
In vitro hydrolysis of novel gamma-linolenoyloxyalkyl derivatives of theophylline
International Journal of Pharmaceutics 1997; 157(1): 81-91.
(Abstract)


724
Cantrill, R.C.; Ells, G.W.; DeMarco, A.C.; Horrobin, D.F.
Mechanisms of the selective cytotoxic actions of certain essential fatty acids [review]
Adv Exp Med Biol 1997; 400A: 539-44.
(Abstract)


725
Corrigan, F.M.; Gray, R.F.; Skinner, E.R.; Strathdee, A.; Horrobin, D.F.
Plasma lipoproteins and apolipoproteins in individuals convicted of violent crimes
In: Hillbrand, M.; Spitz, R.T. (Eds.) Lipids, Health, and Behavior. American Psychological Association, Washington DC. 1997: 167-178.


726
Crellin, A.; Alcock, C.J.; Gudgeon, A.; van Zyl, A.; Horrobin, D.F.; Scott, C.A.
A phase III double-blind, placebo-controlled trial to assess the efficacy of Amelorad in ameliorating radiation-induced normal tissue damage (Abstract)
Presented at: Eicosanoids and Radiation Conference, San Diego, September 1997.


727
DeMarco, A.C.; Morse, N.; Horrobin, D.F.
A single oral bioavailability and bioequivalence study of gamma linolenic acid in healthy volunteers [Poster]
4th International Congress on Fatty Acids, Edinburgh July 1997.


728
Elliot, M.; de Antueno, R.; Smith, M.; Redden, P.; Dowell, T.; Horrobin, D.F.
In vitro and in vivo time-course studies on the metabolism of lithium gammalinolenate in human cancer cells (Abstract)
Proc Am Assoc Cancer Res 1997; 38: 63.


729
Ells, G.W.; Chisholm, K.A.; MacDougall, P.S.; Keil, K.A.; Horrobin, D.F.
Relationship between fatty acid desaturation in tumor cell lines and sensitivity to the cytotoxic effects of gamma-linolenic acid (Abstract)
Proc Am Assoc Cancer Res 1997; 38: 62-3.


730
Horrobin, D.F.
Essential fatty acid metabolism and bone (Abstract)
Bone 1997; 20: 120S.


731
Horrobin, D.F.
Essential fatty acids in the management of impaired nerve function in diabetes [review]
Diabetes 1997; 46(Supp 2): S90-S93.
(Abstract)


732
Horrobin, D.F.
Gamma-linolenic acid in the treatment of diabetic neuropathy
In: Boulton, A.J.M (Ed.) Diabetic Neuropathy. Marius Press, Carnforth, UK. 1997: 183-195.


733
Horrobin, D.F.
Schizophrenia and membrane lipids
In: Hillbrand, M.; Spitz, R.T. (Eds.) Lipids, Health, and Behavior. American Psychological Association, Washington DC. 1997: 179-194.


734
Horrobin, D.F.
Fatty acids, phospholipids, and schizophrenia
In: Yehuda, S.; Mostofsky, D.I. (Eds.) Handbook of Fatty Acid Biology. Humana Press, Totawa, New Jersey. 1997: 245-256.


735
Horrobin, D.F.
Obituary: Sir John Eccles (1903-1997)
Medical Hypotheses 1997; 49(5): 363.


736
Horrobin, D.F.
Essential fatty acid metabolism in patients with diabetic neuropathy
Prostaglandins Leukotr EFAs 1997; 57: 256.


737
Horrobin, D.F.; Glen, A.I.M.; Cantrill, R.C.
Clozapine : elevation of membrane unsaturated lipid levels as a new mechanism of action
Biol Psychiatry (World Congress of Biological Psychiatry, Nice, June 1997) 1997; 42(1 Supp1): 161S.
(Abstract)


738
Horrobin, D.F.; Glen, A.I.M.; Cantrill, R.C.
Clozapine:elevation of membrane unsaturated lipid levels as a new mechanism of action (Abstract)
Scizophr Res 1997; 24: 214.


739
Horrobin, D.F.; Vaddadi, K.S.; Glen, A.I.M.; Cooper, S.; Fahey, J.; Rybakowski, J.; Shay, J.
Arachidonic and docosahexaenoic acid levels in blood in schizophrenics who do and do not flush to oral niacin (Abstract)
Biol Psychiatry (World Congress of Biological Psychiatry, Nice, June 1997) 1997; 42(1 Supp1): 232S.
(Abstract)


740
Horrobin, D.F. and Ziboh, V.A.
The importance of linoleic acid metabolites in cancer metastasis and in the synthesis and actions of 13-HODE [review]
Adv Exp Med Biol 1997; 433: 291-4.
(Abstract)


741
Hrelia, S.; Biagi, P.L.; Lorenzini, A.; Jimenez, J.A.L.; Horrobin, D.F.; Bordoni, A.
Essential fatty acid metabolism in cardiomyocytes grown in media enriched with different n-6/n-3 fatty acid combinations
Biochemistry and Molecular Biology International 1997; 41(2): 423-430.
(Abstract)


742
Jenkins, D.K.; Campbell-Palmer, L.C.; Reeves, K.; Gaul, K.J.; Horrobin, D.F.
Tissue fatty acids changes in a fasting/refeeding animal model [poster]
Presented at: Fourth International Congress on Essential Fatty Acids and Eicosanoids, Edinburgh, July 1997.


743
Jenkins, D.K.; Campbell-Palmer, L.C.; Reeves, K.; Gaul, K.J.; Horrobin, D.F.
Bioavailablity of gamma-linolenate administered as three novel prodrugs [poster]
Presented at: Fourth International Congress on Essential Fatty Acids and Eicosanoids, Edinburgh, July 1997.


744
Jiang, W.G.; Bryce, R.P.; Horrobin, D.F.; Mansel, R.E.
Gamma linolenic acid regulates gap junction communication in endothelial cells and their interaction with tumour cells
Prostaglandins Leukotr EFAs 1997; 56(2): 307-316.


745
Jiang, W.G.; Hiscox, S.; Bryce, R.P.; Horrobin, D.F.; Mansel, R.E.
The effects of n-6 polyunsaturated fatty acids on nm-23 expression in cancer cells
Prostaglandins Leukotrienes and Essential Fatty Acids 1997; 57(2): 206.


746
Jiang, W.G.; Hiscox, S.; Horrobin, D.F.; Bryce, R.P.; Mansel, R.E.
Gamma linolenic acid regulates expression of maspin and the motility of cancer cells
Biochem Biophys Res Commun 1997; 237(3): 639-644.
(Abstract)


747
Jiang, W.G.; Hiscox, S.; Horrobin, D.F.; Bryce, R.P.; Mansel, R.E.
g-Linolenic acid regulates expression of maspin and maspin mediated migration of breast cancer cells
Breast Cancer Research and Treatment 1997; 46(1): 90.


748
Jiang, W.G.; Hiscox, S.; Horrobin, D.F.; Bryce, R.P.; Mansel, R.E.
Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids
Proc Amer Ass Cancer Research 1997; 38: 289.


749
Jiang, W.G.; Hiscox, S.; Horrobin, D.F.; Bryce, R.P.; Mansel, R.E.
Expression of maspin in cancer cells and its regulation by gamma linolenic acid
Prostaglandins Leukotrienes and Essential Fatty Acids 1997; 57(2): 247.


750
Jiang, W.G.; Horrobin, D.F.; Bryce, R.P.; Mansel, R.E.
Secretion of SPARC from breast cancer cell are modi.ed by polyunsaturated fatty acids (Abstract)
Presented at: 20th Annual San Antonio Breast Cancer Symposium, December 3-6 1997.


751
Jiang, W.G.; Singhrao, S.K.; Hiscox, S.; Hallett, M.B.; Bryce, R.P.; Horrobin, D.F.; Puntis, M.C.A.; Mansel, R.E.
Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids
Clin Exp Metastasis 1997; 15(6): 593-602.
(Abstract)


752
Kruger, M.C. and Horrobin, D.F.
Calcium metabolism, osteoporosis and essential fatty acids: a review [review]
Prog Lipid Res 1997; 36(3): 131-151.
(Abstract)


753
Langtry, J.A.A.; Rowland, P.C.; Staughton, R.C.D.; Stewart, J.C.M.; Horrobin, D.F.
Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis
Clin Exp Dermatol 1997; 22(5): 216-9.
(Abstract)


754
Leng, G.C.; Horrobin, D.F.; Smith, F.B.; Ells, K.; Morse-Fisher, N.; Fowkes, F.G.R.
Dietary nutrients and plasma n-3, n-6, saturated and monounsaturated fatty acids
J Nutr Environ Med 1997; 7: 91-100.


755
Leng, G.C.; Lee, A.J.; Fowkes, F.G.; Horrobin, D.F.; Jepson, R.G; Lowe, G.D.; Rumley, A.; Skinner, E.R.; Mowat, B.F.
Randomized controlled trial of antioxidants in intermittent claudication
Vasc Med 1997; 2(4): 279-85.
(Abstract)


756
Martin, F.; Corrigan, F.M.; Donard, O.F.X.; Kelly, J.; Besson, J.A.O.; Horrobin, D.F.
Organotin compounds in trimethyltin-treated rats and in human brain in Alzheimer's disease
Human and Experimental Toxicology 1997; 16(9): 512-515.
(Abstract)


757
Mowat, B.F.; Skinner, E.R.; Wilson, H.M.; Leng, G.C.; Fowkes, F.G.; Horrobin, D.F.
Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease
Atherosclerosis 1997; 131(2): 161-6.
(Abstract)


758
Peet, M.; Murphy, B.; Edwards, R.; Shay, J.; Horrobin, D.F.
Membrane omega-3 fatty acids, diet and depression (Abstract)
Prostaglandins Leukot Essent Fatty Acids 1997; 57: 266.


759
Peet, M.; Murphy, B.; Edwards, R.W.; Horrobin, D.F.
Depletion of docosahexaenoic acid levels in erythrocytel membranes of depressive patients (Abstract)
Biol Psychiatry 1997; 42(1 Supp1): 252S.
(Abstract)


760
Peet, M.; Ramchand, C.N.; Horrobin, D.F.
Cell membrane abnormalities in schizophrenia: Implications for treatment (Abstract)
Biol Psychiatry (World Congress of Biological Psychiatry, Nice, June 1997) 1997; 42(1 Supp1): 185S.
(Abstract)


761
Ward, P.; Sutherland, J.; Glen, E.; Glen, A.I.M.; Horrobin, D.F.
Skin .ushing in response to graded doses of topical niacin:a new test which distinguishes schizophrenics from controls (Abstract)
Schizophr Res 1997; 24: 70.


762
Wilson, H.M.; Corrigan, F.M.; Horrobin, D.F.
Tin and low density lipoprotein fatty acids in plasma from patients with acute myocardial infarction
Trace Elements & Electrolytes 1997; 14(2): 66-68.


763
de Antueno, R.; Bai, M.; Elliot, M.; Morton, J.; Quiroga, P.; Horrobin, D.F.
Biotansformation of diol lipids containing eicosapentaenoic and gammalinolenic acids by human pancreatic carcinoma (Abstract)
Proc Am Assoc Cancer Res 1997; 38: 62.


764
de Antueno, R.; Elliot, M.; Ells, G.; Quiroga, P.; Jenkins, K.; Horrobin, D.F.
In vivo and in vitro biotransformation of the lithium salt of gamma-linolenic acid by three human carcinomas
Br J Cancer 1997; 75(12): 1812-1816.
(Abstract)




All copyrights acknowledged

© Peter Lapinskas 1999-2012 Email Peter Lapinskas Last updated: 3 July 2012

Home      Services      Background      Publications      Resources      Contact